Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell, Jörn M. Schattenberg, Isabelle Leclercq, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 2241-2257
Open Access | Times Cited: 277

Showing 1-25 of 277 citing articles:

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 777
Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages☆
Sander Lefere, Tobias Puengel, Jana Hundertmark, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 4, pp. 757-770
Closed Access | Times Cited: 230
The ménage à trois of autophagy, lipid droplets and liver disease
Yasmina Filali-Mouncef, Catherine J. Hunter, Federica Roccio, et al.
Autophagy (2021) Vol. 18, Iss. 1, pp. 50-72
Open Access | Times Cited: 225
Animal models for liver disease – A practical approach for translational research
Yulia A. Nevzorova, Zoé Boyer-Díaz, Francisco Javier Cubero, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 423-440
Open Access | Times Cited: 194
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Cheng Peng, Alastair G. Stewart, Owen L. Woodman, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 189
Role of the Inflammasome in Liver Disease
Marcelle de Carvalho Ribeiro, Gyöngyi Szabó
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 345-365
Open Access | Times Cited: 184
Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition
Akira Honda, Teruo Miyazaki, Junichi Iwamoto, et al.
Journal of Lipid Research (2019) Vol. 61, Iss. 1, pp. 54-69
Open Access | Times Cited: 167
Metabolic Inflammation—A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease?
Nadine Gehrke, Jörn M. Schattenberg
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1929-1947.e6
Closed Access | Times Cited: 161
Cardio-Metabolic Effects of High-Fat Diets and Their Underlying Mechanisms—A Narrative Review
Jibran A. Wali, Natalia Jarzebska, David Raubenheimer, et al.
Nutrients (2020) Vol. 12, Iss. 5, pp. 1505-1505
Open Access | Times Cited: 161
XCR1+ type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis
Aleksandra Deczkowska, Eyal David, Pierluigi Ramadori, et al.
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 1043-1054
Open Access | Times Cited: 145
TMEM41B acts as an ER scramblase required for lipoprotein biogenesis and lipid homeostasis
Dong Huang, Bolin Xu, Lu Liu, et al.
Cell Metabolism (2021) Vol. 33, Iss. 8, pp. 1655-1670.e8
Open Access | Times Cited: 118
A researcher’s guide to preclinical mouse NASH models
Suchira Gallage, Jose Efren Barragan Avila, Pierluigi Ramadori, et al.
Nature Metabolism (2022) Vol. 4, Iss. 12, pp. 1632-1649
Closed Access | Times Cited: 107
Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD
Simon Wabitsch, Justin McCallen, Olena Kamenyeva, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 748-760
Open Access | Times Cited: 102
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver
Weiguo Fan, Kolade Adebowale, Lóránd Váncza, et al.
Nature (2024) Vol. 626, Iss. 7999, pp. 635-642
Open Access | Times Cited: 87
BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
Tina Zimmermann, Leo Thomas, Tamara Baader-Pagler, et al.
Molecular Metabolism (2022) Vol. 66, pp. 101633-101633
Open Access | Times Cited: 82
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease
Julian M. Yabut, Daniel J. Drucker
Endocrine Reviews (2022) Vol. 44, Iss. 1, pp. 14-32
Open Access | Times Cited: 75
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)
Michèle Vacca, Ioannis Kamzolas, Lea Mørch Harder, et al.
Nature Metabolism (2024) Vol. 6, Iss. 6, pp. 1178-1196
Open Access | Times Cited: 63
Found in translation—Fibrosis in metabolic dysfunction–associated steatohepatitis (MASH)
Shuang Wang, Scott L. Friedman
Science Translational Medicine (2023) Vol. 15, Iss. 716
Open Access | Times Cited: 55
Mediators of necroptosis: from cell death to metabolic regulation
Xiaoqin Wu, Laura E. Nagy, Jérémie Gautheron
EMBO Molecular Medicine (2024) Vol. 16, Iss. 2, pp. 219-237
Open Access | Times Cited: 21
Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets
Seonghwan Hwang, Yong He, Xiaogang Xiang, et al.
Hepatology (2019) Vol. 72, Iss. 2, pp. 412-429
Open Access | Times Cited: 136
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223–enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis
Yong He, Robim M. Rodrigues, Xiaolin Wang, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 3
Open Access | Times Cited: 129
MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
Yong He, Seonghwan Hwang, Yan Cai, et al.
Hepatology (2019) Vol. 70, Iss. 4, pp. 1150-1167
Open Access | Times Cited: 122
Oxidative Stress in NAFLD: Role of Nutrients and Food Contaminants
Clémence Rives, Anne Fougerat, Sandrine Ellero‐Simatos, et al.
Biomolecules (2020) Vol. 10, Iss. 12, pp. 1702-1702
Open Access | Times Cited: 119
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1638-1638
Open Access | Times Cited: 114
Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
Marion Régnier, Arnaud Polizzi, Sarra Smati, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 110
Page 1 - Next Page

Scroll to top